European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

TEVA GmbH, Ulm, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

TEVA GmbH
Pharmachemie GmbH

Identification

Ut
District Court of Ulm HRB 726876
Ut
District Court of Dresden HRB 27829
Ut
District Court of Freiburg HRB 6070
EUID
DEB8537.HRB726876

Address

Graf-Arco-Str. 3, 89079 Ulm, Germany
Radebeul, Germany
Kirchzarten, Germany

Corporate purpose

The distribution, export and import of and trade in medicinal products and medical devices and other dietary or pharmaceutical products.

Financials

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Merger & Acquisition & Control

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

Year 2025 in Dpmam
2 wordmarks: KOPFKLAR, Migräne-Magazin mit Köpfchen …
6 Feb 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholding: AbZ-Pharma GmbH
16 Jan 2024
Word figurative mark: “GIBA German Israeli Brain Alliance“
16 Jan 2024
Word figurative mark: “GIBA German Israeli Brain Alliance“
7 Sept 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholding: AbZ-Pharma GmbH
6 Jun 2023
Authorized signatory (ppa): Gabriele Döring · No longer Authorized signatory (ppa) (1)
17 Oct 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · Shareholding: AbZ-Pharma GmbH
30 Mar 2022
Authorized signatory (ppa) (1)
13 Dec 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020 · Shareholding: AbZ-Pharma GmbH
7 Sept 2021
No longer Managing Director: Zoran Buncic, Christoph Stoller
1 Jun 2021
Patent: Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung
16 Dec 2020
Wordmark: “GRY“
31 Aug 2020
No longer Managing Director: Sascha Glanemann
12 Aug 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholding: AbZ-Pharma GmbH
16 Apr 2020
Wordmark: “Rudotel“
30 Mar 2020
Wordmark: “NEUROCLUSTER“
21 Nov 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · Shareholdings: AbZ Pharma GmbH, TEVA Canada Ltd
Year 2019 in Dpmam
6 trademark filings (1 wordmark, 2 word figurative marks): Awegal, Dreisafol, ESTREVA, LEVOCETI-ABZ …
Year 2019 in Dpmam
6 trademark filings: Doss, Dreisafol, Levocarb, Levocarb-TEVA, Sota-TEVA, ZYTOMEDIN
11 Jul 2019
Authorized signatory (ppa) (1)
12 Apr 2019
No longer Authorized signatory (ppa) (1)
4 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
28 Jan 2019
Managing Director: Zoran Buncic · No longer Managing Director: Miran Denac
13 Sept 2018
Managing Director: Thomas A. Schlenker · No longer Authorized signatory (ppa): Thomas A. Schlenker
30 Aug 2018
Wordmark: “Calci-GRY“
Year 2018 in Dpmam
1 wordmark: Gastracid, LEUPROLIN …
25 Jun 2018
Wordmark: “Dreisalan“
25 Jun 2018
Wordmark: “Dreisavit“
31 May 2018
Patent: Injizierbare Darreichungsform von Flupirtin
16 Apr 2018
Wordmark: “Atrilesto“
16 Apr 2018
Wordmark: “Atrinovir“
6 Dec 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
3 Oct 2017
Patent: Pharmazeutische Zubereitung und deren Verwendung
Year 2017 in Dpmam
9 trademark filings: DREISACARB, Dreisacid, Dreisakon, Dreisalind, Dreisanorm, Dreisapres, Dreisatop, Dreisavan, Dreisyt
25 Sept 2017
Authorized signatory (ppa): Thomas A. Schlenker
27 Jul 2017
Wordmark: “Flupirtit“
27 Jul 2017
Wordmark: “corinfar“
20 Jul 2017
Managing Director: Christoph Stoller · No longer Managing Director: Markus G. Dieken
1 Jul 2017
Patent: Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
1 Jul 2017
Patent: Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
27 Feb 2017
Managing Director: Sascha Glanemann · No longer Managing Director: Ferenc Mark Tracik
16 Feb 2017
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
Year 2016 in Dpmam
1 wordmark: ACCENDO, Atrilesto, BRAINOTOP, BRAINOVIT, Ein gutes Rezept!, FENAX, KATADOLON, Procortan, T-long
14 Sept 2016 via Forest Laboratories Deutschland GmbH also 06/09/2016
Merger: Forest Laboratories Deutschland GmbH
7 Sept 2016
Merger: Forest Laboratories Deutschland GmbH
25 Aug 2016
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Aug 2016
Wordmark: “Atvirenz“
16 Aug 2016
Wordmark: “Atevanor“
8 Aug 2016 via TEVA Pharma GmbH
Merger: TEVA Pharma GmbH
8 Aug 2016
Merger: TEVA Pharma GmbH
29 Jul 2016
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
16 Mar 2016
Patent: Sulfonate Salts of Flupirtine
1 Mar 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
8 Feb 2016
No longer Managing Director: Tihomir Oreskovic
4 Feb 2016
Wordmark: “DREISACAL“
18 Nov 2015
Patent: Multi Component Crystals Made From 2-Amino-3-Carbethoxyamino-6-(4-Fluorobenzylamino)-Pyridine and 2-[2-[(2,6-Dichlorophenyl)-Amino]-Phenyl]-Acetic Acid
Year 2015 in Dpmam
4 word figurative marks: Acimethin, Aquex, Azapress, Calcetat-GRY, Dreisafol, GRY, GRY-Pharma, Gastracid, Gyroflox, Melox-GRY, NAC AWD, Prothazin, RILEX, Suxilep, T-long …
Year 2015 in Dpmam
29 trademark filings: Bicamid-GRY, Calcet, Calci-GRY, DREISACAL, DREISACARB, Doxazoflo, Dreisacid, Dreisafer, Dreisakon, Dreisalan, Dreisalind, Dreisanorm, Dreisapres, Dreisatop, Dreisavan …
26 Feb 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2012 · Shareholdings: AbZ- Pharma GmbH, TEVA Canada Ltd., TEVA Pharma GmbH
20 Jan 2015
Managing Director: Miran Denac · No longer Managing Director (1)
8 Dec 2014
Managing Director: Ferenc Mark Tracik
1 Dec 2014
Managing Director: Andreas M. Burkhardt, Tihomir Oreskovic · No longer Authorized signatory (ppa): Andreas M. Burkhardt
5 Nov 2014
No longer Managing Director (1)
Year 2014 in Dpmam
2 word figurative marks: AKRINOR, AVAMIGRAN, Acimethin, Alebis, Awegal, Azapress, Calcium D3 AWD, Cetalerg, Contrykal, Convulsofin, Cordanum, Dominal, Ein gutes Rezept!, Fentagesic, Finlepsin …
Year 2014 in Dpmam
8 trademark filings: Acimethin, Azapress, Gatonin, Gatonin-GRY, SPORTOFIT, Torasid-GRY, Zweiferro …
4 Sept 2014
No longer Managing Director (1)
10 Jun 2014
Acquisition: AbZ-Pharma GmbH · Break-up: AbZ-Pharma GmbH
28 May 2014
Authorized signatory (ppa): Andreas M. Burkhardt · Managing Director (1) · No longer Managing Director (1)
19 May 2014
Authorized signatory (ppa): Andreas M. Burkhardt · Managing Director (1) · No longer Managing Director (1)
10 Feb 2014
Authorized signatory (ppa): Andreas M. Burkhardt · No longer Managing Director (1)
9 Dec 2013
Managing Director (1)
4 Dec 2013
Managing Director (1)
23 Oct 2013
Patent: Flupirtin Comprising Medicament Formulation with a Controlled Release of the Active Agent
9 Oct 2013
No longer Managing Director (1)
Year 2013 in Dpmam
21 trademark filings (1 wordmark, 2 word figurative marks): Aquex, GRY, GRY-Pharma, Gyroflox, LaPina, RILEX …
7 Oct 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholdings (5 companies)
10 Sept 2013 via TEVA Deutschland GmbH also 04/10/2012, 16/08/2011, 03/11/2010, 27/04/2010, 15/04/2008
Shareholder: TEVA Deutschland GmbH
1 Aug 2013 via AWD.pharma GmbH & Co.KG also 11/07/2013
Merger: AWD.pharma GmbH & Co.KG
Year 2013 in Dpmam
10 trademark filings: Aquex, Domidon, Domidon-GRY, GRY, GRY-Pharma, Gyroflox, HISTINORM, HISTIPLUS, RILEX …
23 Jul 2013
Merger: AWD.pharma GmbH & Co. KG
15 Jul 2013
Merger: AWD.pharma GmbH & Co.KG
26 Jun 2013
Control: TEVA Health GmbH · Control: TEVA Health GmbH
4 Jun 2013
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
22 Jan 2013
Managing Director: Markus G. Dieken
14 Jan 2013
Managing Director: Markus G. Dieken
22 Nov 2012
Original document: “Liste der Gesellschafter“
Year 2012 in Dpmam
14 wordmarks: Aphroforte, Apollong, Azurekt, Calcetat-GRY, Enhanzum, Erotenza, LaPalina, LaPamina, LaPea, LaPla, Letizian, Lontigum, Melox-GRY, Potenon, Valedonis …
25 Oct 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
22 Oct 2012
Merger: TEVA Deutschland GmbH
18 Oct 2012
Wordmark: “Calcetat-GRY“
18 Oct 2012
Wordmark: “Melox-GRY“
1 Aug 2012 via Cephalon GmbH also 25/07/2012, 25/07/2012, 19/07/2012
Merger: Cephalon GmbH
26 Jul 2012
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
24 Jul 2012
Merger: Cephalon GmbH
21 Jun 2012
Patent: Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
21 Jun 2012
Patent: Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
23 Apr 2012
Authorized signatory (ppa) (1)
5 Apr 2012
Authorized signatory (ppa) (1)
20 Dec 2011
Patent: Novel Multicomponent Crystals Made of ([2-Amino-6-(4-Fluoro-Benzylamino)-Pyridin-3-YL]-Carbamic Acid Ethyl Ester and an Arylpropionic Acid
20 Dec 2011
Patent: Multicomponent Crystals Made of ([2-Amino-6- (4-Fluoro-Benzylamino) -Pyridine-3-YL] -Carbamic Acid Ethyl Ester and 2- [2- [(2,6-Dichlorophenyl) -Amino] -Phenyl] -Acetic Acid
15 Dec 2011
Patent: Injizierbare Darreichungsform von Flupirtin
6 Oct 2011
Patent: Pharmazeutische Zubereitung und deren Verwendung
25 Aug 2011
Change of headquarters: TEVA GmbH · Address · Seat: Ulm, Germany
23 Aug 2011
MD (3) · Change of headquarters: TEVA GmbH · Address · Capital: 1,750,000 DEM · Share­holder agreement · Proxy policy · The distribution, export and import of and trade in medicinal products and …
9 Aug 2011
Original document: “Liste der Gesellschafter“
9 Aug 2011
Original document: “Gesellschaftsvertrag / Satzung / Statut“
Year 2011 in Dpmam
86 trademark filings: Acimethin, Aquex, Azapress, Bicamid-GRY, Calcet, Calcetat-GRY, Calci-GRY, DREISACAL, DREISACARB, Domidon, Domidon-GRY, Doss, Doxazoflo, Dreisacid, Dreisafer …
14 Jun 2011
Patent: An Injectable Dosage Form of Flupirtine
9 Jun 2011
Managing Director (1) · No longer Managing Director (1)
27 May 2011
Managing Director (1) · No longer Managing Director (1)
30 Mar 2011
Patent: Pharmazeutische Zubereitung und deren Verwendung
Year 2010 in Dpmap
4 patent filings: Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure …
24 Aug 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
12 Aug 2010 via TEVA Generics GmbH
Merger: TEVA Generics GmbH
12 Aug 2010 via GRY Pharma GmbH
Merger: GRY Pharma GmbH
12 Aug 2010 via IVAX Pharma GmbH
Merger: IVAX Pharma GmbH
12 Aug 2010
Merger (3 companies) · Share­holder agreement · Distribution, export and import of and trade in medicinal products and medical devices and other dietary or pharmaceutical products …
27 May 2010
Wordmark: “Calcet“
27 May 2010
Wordmark: “Calcet“
14 Apr 2010
Wordmark: “Fentagesic“
31 Mar 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
11 Mar 2010
Name: TEVA GmbH
29 Jun 2009 as Pharmachemie GmbH
Change of headquarters: Pharmachemie GmbH
25 Jun 2009 as Pharmachemie GmbH
Managing Director (3) · No longer Managing Director (1) · Change of headquarters: Pharmachemie GmbH · Address · Capital: 1,750,000 DEM · Share­holder agreement · Managing own assets
17 Jun 2009 as Pharmachemie GmbH
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
19 Jan 2009
Address
Year 2008 in Dpmam
4 trademark filings: Levocarb, Levocarb-TEVA, Sota-TEVA, ZYTOMEDIN
21 Aug 2008
Wordmark: “GRY-Pharma“
14 Jul 2008 as Pharmachemie GmbH
Managing Director (1)
5 May 2008 as Pharmachemie GmbH
Managing Director (1) · No longer Managing Director (1)
5 May 2008
Wordmark: “FENTAGESIC“
23 Nov 2007
Wordmark: “Calci-GRY“
23 Nov 2007
Wordmark: “Dreisalan“
23 Nov 2007
Wordmark: “Dreisavit“
Year 2007 in Dpmam
59 trademark filings (3 wordmarks, 2 word figurative marks): ACCENDO, AKRINOR, AVAMIGRAN, Alebis, Awegal, BRAINOTOP, BRAINOVIT, Calcium D3 AWD, Cetalerg, Contrykal, Convulsofin, Cordanum, Dominal …
12 Jul 2007
Patent: Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung
Year 2006 in Dpmam
4 wordmarks: Acimethin, Aquex, Azapress, Calcetat-GRY, Dreisafol, GRY, GRY-Pharma, Gyroflox, Katadolon s long, Katadolon slong, Melox-GRY, RILEX, Score-Kompass, Sumatriptan AWD, Torasid-GRY …
Year 2006 in Dpmam
35 trademark filings: Bicamid-GRY, Calcet, Calci-GRY, DREISACAL, DREISACARB, Domidon, Domidon-GRY, Doxazoflo, Dreisacid, Dreisafer, Dreisakon, Dreisalan, Dreisalind, Dreisanorm, Dreisapres …
12 Apr 2006
Managing Director (2) · No longer Managing Director (1)
9 Mar 2006 as Pharmachemie GmbH
Reg­is­tra­tion · Managing Director (1) · Capital: 1,750,000 DEM · Seat: Kirchzarten, Germany · Legal form · Name: Pharmachemie GmbH · Die Verwaltung eigenen Vermögens
22 Dec 2005
Wordmark: “Ein gutes Rezept!“
9 Nov 2005
Wordmark: “Calcet“
8 Nov 2005
Patent: Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung
12 Jul 2005
Wordmark: “Bicamid-GRY“
28 Feb 2005
Wordmark: “Bicamid-GRY“
There are no publications matching your search.

Mentions

23 Jul 2013 in Hrdk
AbZ-Pharma GmbH: “Liste der Gesellschafter“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "TEVA GmbH, Ulm, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.